Goldman Sachs
BDSI

Goldman Sachs’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Goldman Sachs’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-500,000
Closed -$3.98M – 7796
2015
Q2 		$3.98M Buy
500,000
+423,700
+555% +$3.64M ﹤0.01% 3166
2015
Q1 		$801K Buy
+76,300
New +$1.04M ﹤0.01% 4674

Other funds holding BDSI

CAM
Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return
FCMT
Founders Capital Management (Texas) Houston, Texas $231M AUM 61.68% 1-Year Est. Return

Goldman Sachs's BDSI Position: Q1 2022 in Review

Goldman Sachs sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 402,502 shares — an estimated $1.25M sold.

Goldman Sachs first reported a position in BDSI in Q1 2014 and held it in 29 quarters. The position peaked at $10.9M in Q1 2021. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

  • Goldman Sachs reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
  • Goldman Sachs sold 402,502 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $1.25M.
  • Goldman Sachs first reported a position in BioDelivery Sciences International, Inc. in Q1 2014 and held it in 29 quarters.
  • Goldman Sachs's BioDelivery Sciences International, Inc. position peaked at $10.9M in Q1 2021.
  • 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on Goldman Sachs's 13F filing for Q1 2022, filed 16 May 2022.